Chiropractors in Denham Springs, LA Accepting Medicare
7 Chiropractors found. Showing 1 - 7
 Dr. Richie Reed Roth, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 32350 La Highway 16, Bldg C, Denham Springs, LA 70726 Phone: 225-664-1456 Fax: 866-766-9895 |
Dr. Robert W Ritchie, D. C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 32350 La Highway 16 Bldg C, Denham Springs, LA 70726 Phone: 225-664-1456 Fax: 866-704-8540 |
Dr. Jeffrey James Rippel, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 1680 Benton Ln, Denham Springs, LA 70726 Phone: 225-664-4035 Fax: 225-664-3010 |
 Denham Springs Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1130 S Range Ave, Suite D, Denham Springs, LA 70726 Phone: 225-667-0665 Fax: 225-665-0665 |
Dr. Bishop Currie, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 516 N Range Ave, Denham Springs, LA 70726 Phone: 225-665-3969 |
Dr. Peter Don Dickinson, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 516 N Range Ave, Denham Springs, LA 70726 Phone: 225-665-3969 Fax: 225-665-8139 |
Dr. Joseph Robert Archer, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1130 S Range Ave Ste D, Denham Springs, LA 70726 Phone: 225-665-0667 Fax: 225-664-8037 |
News Archive
Accelr8 announces patent allowance for rapid bacterial diagnostic method
Accelr8 Technology Corporation has announced that it received notice of allowance on the first patent related to its BACcel rapid diagnostic platform.
U.S. Preventive Services Task Force supports Prostate Cancer Screening in men aged 55–69
The Men's Health Network (MHN) is positive on the most recent recommendations of the U.S. Preventive Services Task Force (USPSTF). The task force states that the choice of whether to be screened or not for prostate cancer depends on the men.
QLT board approves increase in share repurchase program
QLT Inc. today announced that, subject to regulatory approval, the Board of Directors has approved an increase in the number of common shares that QLT may purchase under its normal course issuer bid over the twelve month period that commenced on November 3, 2009, from 2,731,534 common shares, representing 5% of the outstanding common shares on October 28, 2009, to 4,700,060 common shares, representing 10% of the public float as at that date.
Amira achieves two clinical development milestones in FLAP program for asthma
"Amira Pharmaceuticals, Inc. announced today that its FLAP (5-lipoxygenase-activating protein) program, which is partnered with GlaxoSmithKline, has achieved two clinical development milestones."
› Verified 5 days ago
Speech-Language Pathologists
Physical Therapists
Occupational Therapists
Optometrists
Chiropractors
Podiatrists
Audiologists